BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1307 related articles for article (PubMed ID: 24170911)

  • 1. Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia.
    Ugajin M; Yamaki K; Hirasawa N; Yagi T
    Respir Care; 2014 Apr; 59(4):564-73. PubMed ID: 24170911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of a semi-quantitative procalcitonin test and the A-DROP Japanese prognostic scale for predicting mortality among adults hospitalized with community-acquired pneumonia.
    Kasamatsu Y; Yamaguchi T; Kawaguchi T; Tanaka N; Oka H; Nakamura T; Yamagami K; Yoshioka K; Imanishi M
    Respirology; 2012 Feb; 17(2):330-6. PubMed ID: 22059525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein, procalcitonin, clinical pulmonary infection score, and pneumonia severity scores in nursing home acquired pneumonia.
    Porfyridis I; Georgiadis G; Vogazianos P; Mitis G; Georgiou A
    Respir Care; 2014 Apr; 59(4):574-81. PubMed ID: 24106319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of procalcitonin level in community-acquired pneumonia in the ED.
    Park JH; Wee JH; Choi SP; Oh SH
    Am J Emerg Med; 2012 Sep; 30(7):1248-54. PubMed ID: 22030193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of procalcitonin in community-acquired pneumonia.
    Schuetz P; Suter-Widmer I; Chaudri A; Christ-Crain M; Zimmerli W; Mueller B;
    Eur Respir J; 2011 Feb; 37(2):384-92. PubMed ID: 20595156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of prognostic factors in hospitalized patients with pneumonia occurring outside hospital: Serum albumin is not less important than pneumonia severity assessment scale.
    Miyazaki H; Nagata N; Akagi T; Takeda S; Harada T; Ushijima S; Aoyama T; Yoshida Y; Yatsugi H; Fujita M; Watanabe K
    J Infect Chemother; 2018 Aug; 24(8):602-609. PubMed ID: 29628384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia.
    Menéndez R; Martínez R; Reyes S; Mensa J; Filella X; Marcos MA; Martínez A; Esquinas C; Ramirez P; Torres A
    Thorax; 2009 Jul; 64(7):587-91. PubMed ID: 19131448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.
    España PP; Capelastegui A; Mar C; Bilbao A; Quintana JM; Diez R; Esteban C; Bereciartua E; Unanue U; Uranga A
    J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia.
    Zhydkov A; Christ-Crain M; Thomann R; Hoess C; Henzen C; Werner Z; Mueller B; Schuetz P;
    Clin Chem Lab Med; 2015 Mar; 53(4):559-66. PubMed ID: 25014522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic value of procalcitonin in community-acquired pneumonia.
    Horie M; Ugajin M; Suzuki M; Noguchi S; Tanaka W; Yoshihara H; Kawakami M; Kichikawa Y; Sakamoto Y
    Am J Med Sci; 2012 Jan; 343(1):30-5. PubMed ID: 22207498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes.
    Krüger S; Ewig S; Marre R; Papassotiriou J; Richter K; von Baum H; Suttorp N; Welte T;
    Eur Respir J; 2008 Feb; 31(2):349-55. PubMed ID: 17959641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial procalcitonin levels for predicting prognosis in community-acquired pneumonia.
    Ito A; Ishida T; Tachibana H; Ito Y; Takaiwa T
    Respirology; 2016 Nov; 21(8):1459-1464. PubMed ID: 27398948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology.
    Bello S; Lasierra AB; Mincholé E; Fandos S; Ruiz MA; Vera E; de Pablo F; Ferrer M; Menendez R; Torres A
    Eur Respir J; 2012 May; 39(5):1144-55. PubMed ID: 22075489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia.
    Ramírez P; Ferrer M; Martí V; Reyes S; Martínez R; Menéndez R; Ewig S; Torres A
    Crit Care Med; 2011 Oct; 39(10):2211-7. PubMed ID: 21705887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?
    Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
    J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ability of procalcitonin to predict bacteremia in patients with community acquired pneumonia].
    Julián-Jiménez A; Timón Zapata J; Laserna Mendieta EJ; Parejo Miguez R; Flores Chacartegui M; Gallardo Schall P
    Med Clin (Barc); 2014 Apr; 142(7):285-92. PubMed ID: 24120103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of serum procalcitonin levels in pulmonary tuberculosis.
    Ugajin M; Miwa S; Shirai M; Ohba H; Eifuku T; Nakamura H; Suda T; Hayakawa H; Chida K
    Eur Respir J; 2011 Feb; 37(2):371-5. PubMed ID: 20530033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index.
    Masiá M; Gutiérrez F; Shum C; Padilla S; Navarro JC; Flores E; Hernández I
    Chest; 2005 Oct; 128(4):2223-9. PubMed ID: 16236878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia. A pilot study.
    Piacentini E; Sánchez B; Arauzo V; Calbo E; Cuchi E; Nava JM
    J Crit Care; 2011 Apr; 26(2):201-5. PubMed ID: 20813489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia.
    Claessens YE; Mathevon T; Kierzek G; Grabar S; Jegou D; Batard E; Loyer C; Davido A; Hausfater P; Robert H; Lavagna-Perez L; Bernot B; Plaisance P; Leroy C; Renaud B
    Intensive Care Med; 2010 May; 36(5):799-809. PubMed ID: 20232049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.